Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment.
Market Analysis and Insights: Global Companion Diagnostic Technologies Market
The global Companion Diagnostic Technologies market size is projected to reach US$ 6057.7 million by 2028, from US$ 2771.3 million in 2021, at a CAGR of 11.3% during 2022-2028.
Companion diagnostics is segmented on the basis of its use for indications such as oncology, cardiovascular conditions, central nervous system indications, inflammation and virology. Oncology is the highest revenue generating segment, as majority of the companion diagnostics have been developed for detection of various cancer biomarkers. The key driver for this market is an increase in research and development of targeted drugs, which require a corresponding companion diagnostic.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Diagnostic Technologies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Diagnostic Technologies market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Diagnostic Technologies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Diagnostic Technologies market.
Global Companion Diagnostic Technologies Scope and Market Size
Companion Diagnostic Technologies market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
- Immunohistochemistry
- Molecular Diagnostics
Segment by Application
- Oncology
- Cardiovascular
- Central Nervous System
- Auto immune & Inflammation
- Virology
- Others
By Company
- Dako (Agilent Technologies)
- Qiagen
- Roche
- Abbott Laboratories
- Thermo Fisher Scientific
- bioMerieux
- Myriad Genetics
- Resonance Health Ltd.
- Leica Microsystems
- Danaher
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
TABLE OF CONTENTS
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Companion Diagnostic Technologies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Immunohistochemistry
- 1.2.3 Molecular Diagnostics
- 1.3 Market by Application
- 1.3.1 Global Companion Diagnostic Technologies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Oncology
- 1.3.3 Cardiovascular
- 1.3.4 Central Nervous System
- 1.3.5 Auto immune & Inflammation
- 1.3.6 Virology
- 1.3.7 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Companion Diagnostic Technologies Market Perspective (2017-2028)
- 2.2 Companion Diagnostic Technologies Growth Trends by Region
- 2.2.1 Companion Diagnostic Technologies Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Companion Diagnostic Technologies Historic Market Size by Region (2017-2022)
- 2.2.3 Companion Diagnostic Technologies Forecasted Market Size by Region (2023-2028)
- 2.3 Companion Diagnostic Technologies Market Dynamics
- 2.3.1 Companion Diagnostic Technologies Industry Trends
- 2.3.2 Companion Diagnostic Technologies Market Drivers
- 2.3.3 Companion Diagnostic Technologies Market Challenges
- 2.3.4 Companion Diagnostic Technologies Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Companion Diagnostic Technologies Players by Revenue
- 3.1.1 Global Top Companion Diagnostic Technologies Players by Revenue (2017-2022)
- 3.1.2 Global Companion Diagnostic Technologies Revenue Market Share by Players (2017-2022)
- 3.2 Global Companion Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Companion Diagnostic Technologies Revenue
- 3.4 Global Companion Diagnostic Technologies Market Concentration Ratio
- 3.4.1 Global Companion Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Technologies Revenue in 2021
- 3.5 Companion Diagnostic Technologies Key Players Head office and Area Served
- 3.6 Key Players Companion Diagnostic Technologies Product Solution and Service
- 3.7 Date of Enter into Companion Diagnostic Technologies Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Technologies Breakdown Data by Type
- 4.1 Global Companion Diagnostic Technologies Historic Market Size by Type (2017-2022)
- 4.2 Global Companion Diagnostic Technologies Forecasted Market Size by Type (2023-2028)
5 Companion Diagnostic Technologies Breakdown Data by Application
- 5.1 Global Companion Diagnostic Technologies Historic Market Size by Application (2017-2022)
- 5.2 Global Companion Diagnostic Technologies Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Companion Diagnostic Technologies Market Size (2017-2028)
- 6.2 North America Companion Diagnostic Technologies Market Size by Type
- 6.2.1 North America Companion Diagnostic Technologies Market Size by Type (2017-2022)
- 6.2.2 North America Companion Diagnostic Technologies Market Size by Type (2023-2028)
- 6.2.3 North America Companion Diagnostic Technologies Market Share by Type (2017-2028)
- 6.3 North America Companion Diagnostic Technologies Market Size by Application
- 6.3.1 North America Companion Diagnostic Technologies Market Size by Application (2017-2022)
- 6.3.2 North America Companion Diagnostic Technologies Market Size by Application (2023-2028)
- 6.3.3 North America Companion Diagnostic Technologies Market Share by Application (2017-2028)
- 6.4 North America Companion Diagnostic Technologies Market Size by Country
- 6.4.1 North America Companion Diagnostic Technologies Market Size by Country (2017-2022)
- 6.4.2 North America Companion Diagnostic Technologies Market Size by Country (2023-2028)
- 6.4.3 U.S.
- 6.4.4 Canada
7 Europe
- 7.1 Europe Companion Diagnostic Technologies Market Size (2017-2028)
- 7.2 Europe Companion Diagnostic Technologies Market Size by Type
- 7.2.1 Europe Companion Diagnostic Technologies Market Size by Type (2017-2022)
- 7.2.2 Europe Companion Diagnostic Technologies Market Size by Type (2023-2028)
- 7.2.3 Europe Companion Diagnostic Technologies Market Share by Type (2017-2028)
- 7.3 Europe Companion Diagnostic Technologies Market Size by Application
- 7.3.1 Europe Companion Diagnostic Technologies Market Size by Application (2017-2022)
- 7.3.2 Europe Companion Diagnostic Technologies Market Size by Application (2023-2028)
- 7.3.3 Europe Companion Diagnostic Technologies Market Share by Application (2017-2028)
- 7.4 Europe Companion Diagnostic Technologies Market Size by Country
- 7.4.1 Europe Companion Diagnostic Technologies Market Size by Country (2017-2022)
- 7.4.2 Europe Companion Diagnostic Technologies Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Companion Diagnostic Technologies Market Size (2017-2028)
- 8.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Type
- 8.2.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Companion Diagnostic Technologies Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Application
- 8.3.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Companion Diagnostic Technologies Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Companion Diagnostic Technologies Market Size by Region
- 8.4.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Companion Diagnostic Technologies Market Size (2017-2028)
- 9.2 Latin America Companion Diagnostic Technologies Market Size by Type
- 9.2.1 Latin America Companion Diagnostic Technologies Market Size by Type (2017-2022)
- 9.2.2 Latin America Companion Diagnostic Technologies Market Size by Type (2023-2028)
- 9.2.3 Latin America Companion Diagnostic Technologies Market Share by Type (2017-2028)
- 9.3 Latin America Companion Diagnostic Technologies Market Size by Application
- 9.3.1 Latin America Companion Diagnostic Technologies Market Size by Application (2017-2022)
- 9.3.2 Latin America Companion Diagnostic Technologies Market Size by Application (2023-2028)
- 9.3.3 Latin America Companion Diagnostic Technologies Market Share by Application (2017-2028)
- 9.4 Latin America Companion Diagnostic Technologies Market Size by Country
- 9.4.1 Latin America Companion Diagnostic Technologies Market Size by Country (2017-2022)
- 9.4.2 Latin America Companion Diagnostic Technologies Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Companion Diagnostic Technologies Market Size (2017-2028)
- 10.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Type
- 10.2.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Companion Diagnostic Technologies Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Application
- 10.3.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Companion Diagnostic Technologies Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Companion Diagnostic Technologies Market Size by Country
- 10.4.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Dako (Agilent Technologies)
- 11.1.1 Dako (Agilent Technologies) Company Details
- 11.1.2 Dako (Agilent Technologies) Business Overview
- 11.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Introduction
- 11.1.4 Dako (Agilent Technologies) Revenue in Companion Diagnostic Technologies Business (2017-2022)
- 11.1.5 Dako (Agilent Technologies) Recent Developments
- 11.2 Qiagen
- 11.2.1 Qiagen Company Details
- 11.2.2 Qiagen Business Overview
- 11.2.3 Qiagen Companion Diagnostic Technologies Introduction
- 11.2.4 Qiagen Revenue in Companion Diagnostic Technologies Business (2017-2022)
- 11.2.5 Qiagen Recent Developments
- 11.3 Roche
- 11.3.1 Roche Company Details
- 11.3.2 Roche Business Overview
- 11.3.3 Roche Companion Diagnostic Technologies Introduction
- 11.3.4 Roche Revenue in Companion Diagnostic Technologies Business (2017-2022)
- 11.3.5 Roche Recent Developments
- 11.4 Abbott Laboratories
- 11.4.1 Abbott Laboratories Company Details
- 11.4.2 Abbott Laboratories Business Overview
- 11.4.3 Abbott Laboratories Companion Diagnostic Technologies Introduction
- 11.4.4 Abbott Laboratories Revenue in Companion Diagnostic Technologies Business (2017-2022)
- 11.4.5 Abbott Laboratories Recent Developments
- 11.5 Thermo Fisher Scientific
- 11.5.1 Thermo Fisher Scientific Company Details
- 11.5.2 Thermo Fisher Scientific Business Overview
- 11.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Introduction
- 11.5.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Technologies Business (2017-2022)
- 11.5.5 Thermo Fisher Scientific Recent Developments
- 11.6 bioMerieux
- 11.6.1 bioMerieux Company Details
- 11.6.2 bioMerieux Business Overview
- 11.6.3 bioMerieux Companion Diagnostic Technologies Introduction
- 11.6.4 bioMerieux Revenue in Companion Diagnostic Technologies Business (2017-2022)
- 11.6.5 bioMerieux Recent Developments
- 11.7 Myriad Genetics
- 11.7.1 Myriad Genetics Company Details
- 11.7.2 Myriad Genetics Business Overview
- 11.7.3 Myriad Genetics Companion Diagnostic Technologies Introduction
- 11.7.4 Myriad Genetics Revenue in Companion Diagnostic Technologies Business (2017-2022)
- 11.7.5 Myriad Genetics Recent Developments
- 11.8 Resonance Health Ltd.
- 11.8.1 Resonance Health Ltd. Company Details
- 11.8.2 Resonance Health Ltd. Business Overview
- 11.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Introduction
- 11.8.4 Resonance Health Ltd. Revenue in Companion Diagnostic Technologies Business (2017-2022)
- 11.8.5 Resonance Health Ltd. Recent Developments
- 11.9 Leica Microsystems
- 11.9.1 Leica Microsystems Company Details
- 11.9.2 Leica Microsystems Business Overview
- 11.9.3 Leica Microsystems Companion Diagnostic Technologies Introduction
- 11.9.4 Leica Microsystems Revenue in Companion Diagnostic Technologies Business (2017-2022)
- 11.9.5 Leica Microsystems Recent Developments
- 11.10 Danaher
- 11.10.1 Danaher Company Details
- 11.10.2 Danaher Business Overview
- 11.10.3 Danaher Companion Diagnostic Technologies Introduction
- 11.10.4 Danaher Revenue in Companion Diagnostic Technologies Business (2017-2022)
- 11.10.5 Danaher Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer